• Explore /
  • Poster
  • / Early efficacy results from atezolizumab (ATZ) with split doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA).

Early efficacy results from atezolizumab (ATZ) with split doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA).

Abstract Poster

Authors

null

Guillermo de Velasco

Medical Oncology Department. Hospital Universitario 12 de Octubre, Madrid, Spain

Guillermo de Velasco , Iciar García-Carbonero , Emilio Esteban-Gonzalez , Alvaro Pinto , David Lorente , Alfonso Gomez De Liano Lista , Esther Martínez Ortega , Laura Jimenez Colomo , Javier Puente , Iria Gonzalez , Ovidio Fernandez-Calvo , Georgia Anguera

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04602078

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 502)

DOI

10.1200/JCO.2023.41.6_suppl.502

Abstract #

502

Poster Bd #

K6

Abstract Disclosures

Similar Posters

First Author: Guru P. Sonpavde

First Author: Alfonso Gomez De Liano Lista

First Author: Xinan Sheng

First Author: Alessandro Morabito